How lipid metabolism shapes sperm development
Sperm cells are among the most specialized in the body, designed for a single purpose: fertilization. Each carries DNA and propels itself toward an egg using a whip-like tail called a flagellum. Inside the testes, sperm develop through several well-defined stages, acquiring the structures and molecules needed for fertilization.
One crucial part of this transformation is the production of seminolipids, specialized fats found in developing sperm that are essential for their formation and function. Seminolipids are synthesized by fatty acyl-CoA reductase, or FAR, enzymes. Mammals have two different FAR enzymes, FAR1 and FAR2.
Although both FAR1 and FAR2 are known to synthesize fatty alcohols, their specific roles in seminolipid production had remained unclear. To pinpoint which enzyme was responsible, Ayano Tamazawa and colleagues at Hokkaido University analyzed mice lacking Far1 and Far2 to clarify their roles in seminolipid production and spermatogenesis. They found that loss of Far1 led to a dramatic decrease in seminolipids and impaired sperm development. The study was published in the Journal of Biological Chemistry.
Tamazawa said the findings show how the loss of seminolipids disrupts spermatogenesis, emphasizing the critical role of ether linkages in sperm development.
Seminolipids are categorized by the types of alkyl and acyl chains they contain, which differ in length and saturation. The most common seminolipid in the testis is O-C16:0/C16:0. Using liquid chromatography–tandem mass spectrometry, or LC–MS/MS, the researchers mapped the exact structure of these lipids.
High-resolution lipidomics analysis of seminolipids and SGalDAGs (3-sulfogalactosyl-1-acyl-2-acylglycerols) showed that both lipid types have similar side chains composed of saturated acyl or alkyl groups. The main difference is that SGalDAGs have a 1-acyl group, whereas seminolipids have a 1-alkyl group.
“This finding is unique because SGalDAGs have never been characterized in detail in the testis,” Tamazawa said.
However, the precise mechanisms by which seminolipids contribute to spermatogenesis, and why the C16:0/C16:0 structure predominates, remain unknown.
The researchers suggest that understanding seminolipid function could inform new diagnostic or therapeutic strategies for male infertility, potentially leading to lipid supplements or biomarkers.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Building a better model for drug delivery across the blood–brain barrier
Industry and academic scientists collaborated to develop a rat with humanized iron-transport receptors, enabling research into iron homeostasis and drugs that cross the brain’s barrier.

Fat synthesis enzyme crucial for milk fat and newborn growth
Researchers found that a deficiency of the fatty acid synthesis enzyme stearoyl-CoA desaturase-1 reduced mammary gland function during lactation and caused low birth weight in newborns that were fed milk from enzyme-deficient glands.

Flipping lipids and slime molds
A dull first job nearly pushed JBC associate editor Todd Graham out of science. Then a slime mold project changed his path. Now, he studies membrane biology and reflects on discovery, persistence and mentoring through uncertainty.

How smelling death alters worm behavior
Researchers have found that the roundworm C. elegans can smell death, and it changes how the worms behave, reproduce and age.

A chance encounter with the lab
Payton Stevens never planned to become a pancreatic cancer researcher. A temporary job set him on a path from rural Kentucky to leading research on Wnt signaling and metastasis, where he now pairs discovery with mentorship and science advocacy.

Light-activated small molecule could transform eye infection treatment
Contact lenses raise the risk of infectious keratitis, a leading cause of blindness worldwide. A biotech company is commercializing a light-activated therapy using a ROS-generating molecule to rapidly kill microbes in the cornea to preserve vision.